Literature DB >> 10543947

Crystal structure of human catecholamine sulfotransferase.

L M Bidwell1, M E McManus, A Gaedigk, Y Kakuta, M Negishi, L Pedersen, J L Martin.   

Abstract

Sulfonation, like phosphorylation, can modify the activity of a variety of biological molecules. The sulfotransferase enzymes sulfonate neurotransmitters, drugs, steroid hormones, dietary carcinogens and proteins. SULT1A3 specifically sulfonates catecholamines such as dopamine, adrenaline and noradrenaline. The crystal structure of SULT1A3 with a sulfate bound at the active site, has been determined at 2.4 A resolution. Although the core alpha/beta fold is like that of estrogen and heparan sulfotransferases, major differences occur in and around the active site. Most notably, several regions surrounding the active site, including a section of 40 residues, are disordered in SULT1A3. Regions that are topologically equivalent to the disordered parts of SULT1A3 are involved in substrate and cofactor binding in estrogen and heparan sulfotransferase. Flexibility in these regions suggests that ligand binding elicits a disorder-order transition in and around the active site of sulfotransferases and might contribute to the broad substrate specificity of these enzymes. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543947     DOI: 10.1006/jmbi.1999.3153

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  25 in total

1.  Mechanistic studies of beta-arylsulfotransferase IV.

Authors:  Eli Chapman; Marian C Bryan; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-23       Impact factor: 11.205

2.  Observation of a hybrid random ping-pong mechanism of catalysis for NodST: a mass spectrometry approach.

Authors:  Na Pi; Yonghao Yu; Joseph D Mougous; Julie A Leary
Journal:  Protein Sci       Date:  2004-04       Impact factor: 6.725

3.  Crystal structure of sulfotransferase STF9 from Mycobacterium avium.

Authors:  Md Murad Hossain; Yuuji Moriizumi; Shotaro Tanaka; Makoto Kimura; Yoshimitsu Kakuta
Journal:  Mol Cell Biochem       Date:  2011-09-30       Impact factor: 3.396

4.  Effects of human SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3.

Authors:  Ahsan F Bairam; Mohammed I Rasool; Fatemah A Alherz; Maryam S Abunnaja; Amal A El Daibani; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  Arch Biochem Biophys       Date:  2018-04-26       Impact factor: 4.013

5.  Crystal structure of ATP sulfurylase from Saccharomyces cerevisiae, a key enzyme in sulfate activation.

Authors:  T C Ullrich; M Blaesse; R Huber
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

Review 6.  New targets and inhibitors of mycobacterial sulfur metabolism.

Authors:  Hanumantharao Paritala; Kate S Carroll
Journal:  Infect Disord Drug Targets       Date:  2013-04

7.  Sulfation of catecholamines and serotonin by SULT1A3 allozymes.

Authors:  Ahsan F Bairam; Mohammed I Rasool; Fatemah A Alherz; Maryam S Abunnaja; Amal A El Daibani; Saud A Gohal; Katsuhisa Kurogi; Yoichi Sakakibara; Masahito Suiko; Ming-Cheh Liu
Journal:  Biochem Pharmacol       Date:  2018-03-08       Impact factor: 5.858

8.  An unusually small dimer interface is observed in all available crystal structures of cytosolic sulfotransferases.

Authors:  Brian Weitzner; Thomas Meehan; Qifang Xu; Roland L Dunbrack
Journal:  Proteins       Date:  2009-05-01

9.  Arginine residues in the active site of human phenol sulfotransferase (SULT1A1).

Authors:  Guangping Chen; Xinrong Chen
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

Review 10.  Drug targets in mycobacterial sulfur metabolism.

Authors:  Devayani P Bhave; Wilson B Muse; Kate S Carroll
Journal:  Infect Disord Drug Targets       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.